MX9301736A - Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. - Google Patents

Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.

Info

Publication number
MX9301736A
MX9301736A MX9301736A MX9301736A MX9301736A MX 9301736 A MX9301736 A MX 9301736A MX 9301736 A MX9301736 A MX 9301736A MX 9301736 A MX9301736 A MX 9301736A MX 9301736 A MX9301736 A MX 9301736A
Authority
MX
Mexico
Prior art keywords
pasteurella haemolytica
bacterine
toxoid vaccine
haemolytica type
vaccine
Prior art date
Application number
MX9301736A
Other languages
English (en)
Inventor
Rex Steven Newsham
Albert L Brown
Krishnaswamy Iyengar Dayalu
Thomas James Kaufman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9301736A publication Critical patent/MX9301736A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Abstract

Esta invención se refiere al campo de las vacunas de pasteurella haemolytica. Más particularmente, la invención se refiere a una vacuna de bacterina-toxoide, capaz de inducir inmunidad en especies bovinas en una sola dosis contra infecciones tipo A-1 de pasteurella haemolytica, que comprende pasteurella haemolytica derivada de leucotoxoide, antígeno capsular, antígenos solubles y células inactivas, método para formar la vacuna y método para vacunar animales bovinos.
MX9301736A 1992-03-30 1993-03-26 Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. MX9301736A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86037792A 1992-03-30 1992-03-30
US86993492A 1992-04-16 1992-04-16
US87814692A 1992-05-04 1992-05-04

Publications (1)

Publication Number Publication Date
MX9301736A true MX9301736A (es) 1994-01-31

Family

ID=27420408

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301736A MX9301736A (es) 1992-03-30 1993-03-26 Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.

Country Status (12)

Country Link
EP (1) EP0636030B1 (es)
JP (1) JP2776982B2 (es)
AT (1) ATE258445T1 (es)
AU (2) AU3970093A (es)
BR (1) BR9306187A (es)
CA (1) CA2133108C (es)
DE (1) DE69333402T2 (es)
DK (1) DK0636030T3 (es)
ES (1) ES2211866T3 (es)
MX (1) MX9301736A (es)
PT (1) PT636030E (es)
WO (1) WO1993019779A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
ATE533506T1 (de) 2002-08-26 2011-12-15 Pfizer Prod Inc Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
CA3161295A1 (en) * 2014-07-11 2016-01-14 Zoetis Services Llc Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
EP3261668A4 (en) 2015-02-27 2018-10-24 Iowa State University Research Foundation, Inc. Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
CN107569681B (zh) * 2017-08-30 2022-02-15 中国农业科学院哈尔滨兽医研究所 一种牛多杀性巴氏杆菌病二价灭活疫苗及其制备方法
WO2022072431A1 (en) * 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1441098A (en) * 1972-03-29 1976-06-30 Wellcome Found Biological preparations
CA1133829A (en) * 1978-08-24 1982-10-19 Neil J.L. Gilmour Pasteurellosis vaccines
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE69031351T2 (de) * 1990-04-05 1998-02-05 Univ Saskatchewan Zubereitungen und behandlungen von pneumonia in tieren
US5114849A (en) * 1990-10-26 1992-05-19 Weyerhaeuser Company Protectants for microbial fermentation

Also Published As

Publication number Publication date
EP0636030B1 (en) 2004-01-28
EP0636030A1 (en) 1995-02-01
DE69333402D1 (en) 2004-03-04
DK0636030T3 (da) 2004-04-05
JPH07505629A (ja) 1995-06-22
ATE258445T1 (de) 2004-02-15
DE69333402T2 (de) 2004-12-09
BR9306187A (pt) 1997-10-07
CA2133108C (en) 2005-01-25
AU707841B2 (en) 1999-07-22
AU3970093A (en) 1993-11-08
PT636030E (pt) 2004-05-31
EP0636030A4 (en) 1996-02-07
ES2211866T3 (es) 2004-07-16
JP2776982B2 (ja) 1998-07-16
AU6435596A (en) 1996-11-07
WO1993019779A1 (en) 1993-10-14
CA2133108A1 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE69030172T2 (de) Impfstoffe gegen Krebs und Infektionskrankheiten
DK174416B1 (da) Oligopeptider, immunogene konjugater heraf med et antigen samt vacciner indeholdende disse konjugater
DK1089760T3 (da) Kunstige T-hjælpecelleepitoper som immunstimulatorer for syntetiske peptidimmunogener
ATE475668T1 (de) Immunisierung durch impfung von dns transkriptionseinheit
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
DE69031351D1 (de) Zubereitungen und behandlungen von pneumonia in tieren
TW340873B (en) Chicken anaemia agent vaccine
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
ATE222930T1 (de) Antigene arznei zur behandlung oder vorbeugung
ATE149569T1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
NO307815B1 (no) Levende eller inaktivert parental vaksine mot rotavirusinfeksjon
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
GB9303681D0 (en) Vaccines
DK0563288T3 (da) Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner
Rethy Experimental-epidemiological studies on the immunological interactions between live and/or killed virus vaccines applied simultaneously with inactivated monovalent or combined vaccines. Survey of human results achieved between 1960-1978.
RU95121713A (ru) Способ одновременной профилактики менингококковой инфекции, дифтерии, брюшного тифа, натуральной оспы, гриппа и вирусного гепатита